In the midst of a 55% increase in chikungunya cases this year, the health department is planning to perform genetic sequencing on samples to identify potential mutations. Uncommon symptoms such as hyperpigmentation and neurological issues have been observed. State health officials clarified that these purported new symptoms are rare and could be a result of concurrent infections like dengue or Japanese encephalitis. Additionally, a rapid action team has been established to investigate the surge in chikungunya cases. Guidelines have been issued for the collection and analysis of samples, including sending blood samples from patients exhibiting neurological symptoms for further testing. The goal is to detect any neurotropic viruses in chikungunya patients and conduct genomic sequencing to identify mutations."We will prioritize sequencing once we receive sufficient samples, particularly from ICU patients or those with severe symptoms," stated a medical professional. Private hospitals in the city reported a significant increase in chikungunya cases this year, leading to some patients requiring hospitalization due to prolonged high fever and neurological issues for about 10 to 15 days. The incidence of chikungunya has also affected children this year, as evidenced by the admission of an eight-month-old boy at SRCC Children's Hospital in Haji Ali in early August. Dr. Bhupendra Avasthi, a pediatrician at Surya Children's Hospital in Santa Cruz, observed hyperpigmentation in children born to mothers who tested positive for chikungunya, noting that hyperpigmentation is a commonly observed symptom of the disease.